Background.:To determine the pathologic complete response rate of advanced ovarian cancer to weekly paclitaxel plus gemcitabine and carboplatin with filgrastim,and assess the longitudinal impact of this regimen on qua...
Objectives.:Platinum resistance is a significant problem in patients with ovarian cancer. The aim of this phase II study was to define the response rates,the progression-free survival and the toxicity profile of the c...